 | |
| Clinical data | |
|---|---|
| Trade names | Xynor |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Via liver[1]: 1356 |
| Eliminationhalf-life | 12-13 hours[1]: 1356 |
| Excretion | Urine (63%) and Feces (22%) |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.037.099 |
| Chemical and physical data | |
| Formula | C7H10ClN3O3 |
| Molar mass | 219.63 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Ornidazole is an antibiotic used to treatprotozoan infections.[1]: 1368 A synthetic nitroimidazole, it is commercially obtained from an acid-catalyzed reaction between 2-methyl-5-nitroimidazole andepichlorohydrin.[2] Ornidazole is nothing but chloro-secnidazole.
Antimicrobial spectrum is similar to that ofmetronidazole and is more well tolerated;[1]: 1368 however there are concerns of lower relative efficacy.[3]
It was first introduced for treatingtrichomoniasis before being recognized for its broad anti-protozoan and anti-anaerobic-bacterial capacities.[4]: 1261 has also been investigated for use inCrohn's disease after bowel resection.[5]
 | Thisantiinfectivedrug article is astub. You can help Wikipedia byexpanding it. |
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |